Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
Clinical trial NCT02743741 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02743741
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-15
- Primary completion
- 2026-06-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.